Skip to content

SYUS

Absorbed by VISMED KBO/BCE: BE 0598.726.065 subsidiary of SYUS INVEST
Part of the group ALTRO MODO 17 companies
See the group

Last board

1 director, last change in 2023
F.M.E BV
Director
since 01-06-2017
listed in the 2023 annual accounts, filed on 14-05-2024

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
F.M.E BV
Director
Finance & Management Executives
Director
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
  • F.M.E BV
    • Director, from 01-06-2017 to date
  • Finance & Management Executives
    • Manager, until 26-10-2023
    • Director, from before 26-10-2023, no longer listed in the 2023 annual accounts

Control

Parent
Equity €891,691
Profit €4.2m in 2023 (profit €3.1m in 2022)
100%
This company
SYUS
Equity €290,361
Profit €104,075 in 2023

Further up the chainALTRO MODO 100%

Capital

Contribution
€18,600
Source
2023 annual accounts

Owners through the years

as the annual accounts name them
67% until 2016
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 26-10-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Artikel 11, algemene vergadering bepaalt aantal duur opdracht en bij meerdere bevoegdheid”
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Artikel 9, instemming ten minste helft aandeelhouders die tenminste drie/vierde aandelen bezitten na aftrek rechten waarvan overdracht…”

Capital transactions

Shareholders according to the deeds
  • VISMED (BE 0598.725.075) €784,699.45

Next steps